Nascent Biotech, Inc. (NBIO)

Nascent Biotech Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	0.37	0.37	0.17	0.09	0	0
Cash & Short-Term Investments	0.37	0.37	0.17	0.09	0	0
Cash Growth	116.12%	116.12%	82.37%	6479.37%	-55.41%	-97.55%
Receivables	-	-	-	-	0.75	-
Prepaid Expenses	0.18	0.18	0.08	0.01	-	-
Total Current Assets	0.55	0.55	0.26	0.11	0.75	0
Total Assets	0.55	0.55	0.26	0.11	0.75	0
Accounts Payable	0.69	0.69	0.5	0.78	0.64	0.85
Accrued Expenses	-	-	-	-	-	1.28
Short-Term Debt	0.12	0.12	0.39	-	0.16	0.14
Other Current Liabilities	-	-	0.66	-	0.43	0.6
Total Current Liabilities	0.81	0.81	1.55	0.78	1.22	2.88
Total Liabilities	0.81	0.81	1.55	0.78	1.22	2.88
Common Stock	0.17	0.17	0.13	0.11	0.1	0.04
Additional Paid-In Capital	23.83	23.83	20.19	18.04	17.77	13.92
Retained Earnings	-24.26	-24.26	-21.62	-18.82	-18.35	-16.84
Total Common Equity	-0.26	-0.26	-1.3	-0.67	-0.47	-2.88
Shareholders' Equity	-0.26	-0.26	-1.3	-0.67	-0.47	-2.88
Total Liabilities & Equity	0.55	0.55	0.26	0.11	0.75	0
Total Debt	0.12	0.12	0.39	-	0.16	0.14
Net Cash (Debt)	0.25	0.25	-0.22	0.09	-0.16	-0.14
Net Cash Per Share	0.00	0.00	-0.00	0.00	-0.00	-0.00
Filing Date Shares Outstanding	172.2	172.2	141.4	115.01	107.73	48.27
Total Common Shares Outstanding	170.59	170.59	131.76	111.31	104.83	44.89
Working Capital	-0.26	-0.26	-1.3	-0.67	-0.47	-2.88
Book Value Per Share	-0.00	-0.00	-0.01	-0.01	-0.00	-0.06
Tangible Book Value	-0.26	-0.26	-1.3	-0.67	-0.47	-2.88
Tangible Book Value Per Share	-0.00	-0.00	-0.01	-0.01	-0.00	-0.06

Source: S&P Capital IQ. Standard template.